Association of renin–angiotensin–aldosterone system gene polymorphisms with left ventricular hypertrophy in patients with heart failure with preserved ejection fraction: A case–control study

References

• Garg N, Senthilkumar A, Nusair MB, et al. Heart failure with a normal left ventricular ejection fraction: epidemiology, pathophysiology, diagnosis and management. Am J Med Sci 2013;346(2):129–36.
   PubMed Web of Science ®Google Scholar
• Rigolli M, Whalley GA. Heart failure with preserved ejection fraction. JGC 2013;10(4):369–76.
   Google Scholar
• Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003;362(9386):777–81.
   PubMed Web of Science ®Google Scholar
• Sutton MG, Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 2000;101(25):2981–8.
   PubMed Web of Science ®Google Scholar
• Diez J, Querejeta R, Lopez B, et al. Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 2002;105(21):2512–7.
   PubMed Web of Science ®Google Scholar
• Deng AY. Genetics of diastolic heart failure. J Hypertens 2013;31(12):2329–36.
   PubMed Web of Science ®Google Scholar
• Keavney B, McKenzie C, Parish S, et al. Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. Lancet 2000;355(9202):434–42.
   PubMed Web of Science ®Google Scholar
• Niu T, Chen X, Xu X. Angiotensin converting enzyme gene insertion/deletion polymorphism and cardiovascular disease: therapeutic implications. Drugs 2002;62(7):977–93.
   PubMed Web of Science ®Google Scholar
• Bahramali E, Rajabi M, Jamshidi J, et al. Association of ACE gene D polymorphism with left ventricular hypertrophy in patients with diastolic heart failure: a case-control study. BMJ Open 2016;6(2):e010282.
   PubMed Web of Science ®Google Scholar
• Firouzabadi N, Shafiei M, Bahramali E, et al. Association of angiotensin-converting enzyme (ACE) gene polymorphism with elevated serum ACE activity and major depression in an Iranian population. Psychiatry Res 2012; 200 (2–3): 336–42.
   PubMed Web of Science ®Google Scholar
• Zhu X, Bouzekri N, Southam L, et al. Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am J Hum Genet 2001;68(5):1139–48.
   PubMed Web of Science ®Google Scholar
• Mottl AK, Shoham DA, North KE. Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: a HuGE review. Genet Med 2008;10(8):560–74.
   PubMed Web of Science ®Google Scholar
• Paulus WJ, Tschope C, Sanderson JE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007;28(20):2539–50.
   PubMed Web of Science ®Google Scholar
• Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57(6):450–8.
   PubMed Web of Science ®Google Scholar
• Quinones MA, Otto CM, Stoddard M, et al. Recommendations for quantification of Doppler echocardiography: a report from the Doppler quantification task force of the nomenclature and standards committee of the American Society of Echocardiography. J Am Soc Echocardiog 2002;15(2):167–84.
   PubMed Web of Science ®Google Scholar
• Bahramali E, Firouzabadi N, Jonaidi-Jafari N, Shafiei M. Renin–angiotensin system genetic polymorphisms: lack of association with CRP levels in patients with coronary artery disease. J Renin Angiotensin Aldosterone Syst 2013:1470320312474051.
   Google Scholar
• Gonzalez JR, Armengol L, Sole X, et al. SNPassoc: an R package to perform whole genome association studies. Bioinformatics 2007;23(5):644–5.
   PubMed Web of Science ®Google Scholar
• Mansoor G, White W. Left Ventricular Hypertrophy and Diastolic Dysfunction. Hypertension Medicine. New York: Springer; 2001, pp. 99–109.
   Google Scholar
• Lindpaintner K, Lee MA, Larson MG, et al. Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. New Engl J Med 1996;334(16):1023–8.
   PubMed Web of Science ®Google Scholar
• Takami S. Angiotensin II Type 1 Receptor gene polymorphism is associated with increase of left ventricular mass but not with hypertension. Am J Hypertens 1998;11(3):316–21.
   PubMed Web of Science ®Google Scholar
• Kannel WB. Blood pressure as a cardiovascular risk factor - Prevention and treatment. JAMA 1996;275(20):1571–6.
   PubMed Web of Science ®Google Scholar
• Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 1991;83(6):1849–65.
   Google Scholar
• Mohammed SF, Hussain S, Mirzoyev SA, et al. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction. Circulation 2015;131(6):550–9.
   PubMed Web of Science ®Google Scholar
• Baker KM, Chernin MI, Wixson SK, Aceto JF. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am J Physiol 1990; 259 (2 Pt 2): H324–32.
   PubMed Web of Science ®Google Scholar
• Takaguri A, Shirai H, Kimura K, et al. Caveolin-1 negatively regulates a metalloprotease-dependent epidermal growth factor receptor transactivation by angiotensin II. J Mol Cell Cardiol 2011;50(3):545–51.
   PubMed Web of Science ®Google Scholar
• Gray MO, Long CS, Kalinyak JE, et al. Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-β1 and endothelin-1 from fibroblasts. Cardiovasc Res 1998;40(2):352–63.
   PubMed Web of Science ®Google Scholar
• Johnston CI. Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling. Hypertension 1994;23(2):258–68.
   PubMed Web of Science ®Google Scholar
• Tiret L, Rigat B, Visvikis S, et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin-I-converting enzyme (Ace) gene controls plasma ace levels. Am J Hum Genet 1992;51(1):197–205.
   PubMed Web of Science ®Google Scholar
• Firouzabadi N, Ghazanfari N, Alavi Shoushtari A, et al. Genetic variants of angiotensin-converting enzyme are linked to autism: a case-control study. PloS one 2016;11(4):e0153667.
   PubMed Web of Science ®Google Scholar
• Firouzabadi N, Tajik N, Bahramali E, et al. Gender specificity of a genetic variant of angiotensin-converting enzyme and risk of coronary artery disease. Mol Biol Rep 2013;40(8):4959–65.
   PubMed Web of Science ®Google Scholar
• Wu CK, Tsai CT, Chang YC, et al. Genetic polymorphisms of the angiotensin II type 1 receptor gene and diastolic heart failure. J Hypertens 2009;27(3):502–7.
   PubMed Web of Science ®Google Scholar
• Jin Y, Kuznetsova T, Thijs L, et al. Association of left ventricular mass with the AGTR1 A1166C polymorphism. Am J Hypertens 2012;25(4):472–8.
   PubMed Web of Science ®Google Scholar
• Firouzabadi N, Tajik N, Bahramali E, et al. Association of angiotensin-converting enzyme polymorphism with coronary artery disease in Iranian patients with unipolar depression. Clin Biochem 2012; 45 (16–17): 1347–52.
   PubMed Web of Science ®Google Scholar
• Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 2013;62(16):1495–539.
   Web of Science ®Google Scholar